Brief: Abbisko Cayman Says Unit Granted Therapy Designation By Center For Drug Evaluation Of NMPA
July 20 (Reuters) - Abbisko Cayman Ltd 2256.HK :
* UNIT HAS BEEN GRANTED THERAPY DESIGNATION BY CENTER FOR
DRUG
EVALUATION OF NMPA FOR TREATMENT OF TENOSYNOVIAL GIANT CELL
TUMOR
Source text for Eikon: ID:nHKS5MLjtW
Further company coverage: 2256.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Cayman
See all newsHK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)
Brief: Abbisko Therapeutics Deepens R+D- Collaboration With Lilly
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Brief: Abbisko Therapeutics Enters Strategic Research Collaboration And License Agreement With Eli Lilly